1329 related articles for article (PubMed ID: 20540826)
1. Gut microbiota in obesity and metabolic disorders.
Sanz Y; Santacruz A; Gauffin P
Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
[TBL] [Abstract][Full Text] [Related]
2. [Role of probiotics in obesity management].
Prados-Bo A; Gómez-Martínez S; Nova E; Marcos A
Nutr Hosp; 2015 Feb; 31 Suppl 1():10-8. PubMed ID: 25659049
[TBL] [Abstract][Full Text] [Related]
3. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
Diamant M; Blaak EE; de Vos WM
Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
[TBL] [Abstract][Full Text] [Related]
4. The gut microbiota, obesity and insulin resistance.
Shen J; Obin MS; Zhao L
Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E; Ricart W; Fernández-Real JM
Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH; DiBaise JK; McClain CJ
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
[TBL] [Abstract][Full Text] [Related]
7. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM; Fava F; Viola R
Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and the development of obesity.
Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
[TBL] [Abstract][Full Text] [Related]
9. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
[TBL] [Abstract][Full Text] [Related]
10. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
11. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
Cani PD; Delzenne NM
Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
13. Interaction between obesity and the gut microbiota: relevance in nutrition.
Delzenne NM; Cani PD
Annu Rev Nutr; 2011 Aug; 31():15-31. PubMed ID: 21568707
[TBL] [Abstract][Full Text] [Related]
14. [Research advances in the gut microbiota and inflammation in obesity].
Cao ZJ; Yu JC; Kang WM; Ma ZQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):462-5. PubMed ID: 23987498
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
16. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
[TBL] [Abstract][Full Text] [Related]
17. Obesity, metabolic syndrome, and microbiota: multiple interactions.
Tilg H
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
Escobedo G; López-Ortiz E; Torres-Castro I
Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrates and the human gut microbiota.
Chassard C; Lacroix C
Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):453-60. PubMed ID: 23719143
[TBL] [Abstract][Full Text] [Related]
20. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
Caesar R; Fåk F; Bäckhed F
J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]